Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference70 articles.
1. Teoh LJ, Solebo AL, Rahi JS, Morton C, Allen L, McPhee D, et al. Visual impairment, severe visual impairment, and blindness in children in Britain (BCVIS2): a national observational study. Lancet Child Adolesc Health [Internet]. 2021;5:190–200.
2. NICE health technology evaluations: the manual (PMG36). 2022.
3. Burton MJ, Ramke J, Marques AP, Bourne RRA, Congdon N, Jones I, et al. The Lancet Global Health Commission on global eye health: vision beyond 2020. Lancet Glob Health [Internet]. 2021;9:e489-551.
4. Cost effectiveness of eye health treatments—The International Agency for the Prevention of Blindness [Internet]. https://www.iapb.org/learn/vision-atlas/solutions/cost-effectiveness/. Accessed 15 Dec 2021.
5. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Revista Espanola de Nutricion Humana y Dietetica [Internet]. 2016;20:148–60. https://doi.org/10.1186/2046-4053-4-1.